Talent Trends: Keeping Yourself Safe When Navigating the Salary Ban
As a leader, you’re always juggling numerous initiatives. From deadlines to budgets, conferences to trade shows, presentations to...
INSIGHTS HUB
2021 – The Pandemic’s Surprising Impact on Hiring in the Life Sciences
Yes – Harder. While this seems counter-intuitive, the actual demand for talent in the Medical Device, Pharma and Biotech industries has...
Search
Pheon Therapeutics Launches with $68 Million in Financing Treatment of Solid Tumors
London, UK, September 28, 2022 (PRNewswire) -- Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist...
Adhera Therapeutics Announces CEO, Senior Management Changes, Plans for NASDAQ Uplist
Baton Rouge, LA, September 19, 2022 (Globe Newswire) -- Adhera Therapeutics, Inc. (OTCQB: ATRX) ("Adhera" or the "Company"), a clinical...
MicroTransponder Closes $73M in Series E Financing
Austin, TX, September 21, 2022 (FinSMEs) -- MicroTransponder, an Austin, TX-based company focused on restoring dignity and enhancing...
Gamida Cell Appoints Abigail L. Jenkins as President and Chief Executive Officer
Boston, MA, September 19, 2022 (Business Wire) -- Gamida Cell Ltd. (Nasdaq: GMDA), the global leader in the development of NAM-enabled...
Sanofi pays Scribe $25M with a future potential of $1B – CRISPR for Cancer
Alameda, CA, September 27, 2022 (Business Wire) -- Scribe Therapeutics Inc., a molecular engineering company pioneering a CRISPR by...
Alphabet's Verily raises $1 bln in funding round
Los Angeles, CA, September 10, 2022 (Reuters) -- Alphabet Inc's (GOOGL.O) health technology arm Verily said on Friday it had raised $1...
Miach Orthopaedics Appoints Patrick McBrayer President & CEO
Westborough, MA, September 7, 2022 (Business Wire) -- Miach Orthopaedics, Inc., a company transforming the treatment of anterior...
ProMIS Neurosciences appoints biopharmaceutical leader, Dr. Gail M. Farfel, as Chief Executive Offic
Toronto, Ontario & Cambridge, MA, September 13, 2022 (Globe Newswire) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN) (TSX: PMN), a...
ACELYRIN, INC. Announces $300 Million Series C Financing
Los Angeles, CA, September 13, 2022 (PRNewswire) -- ACELYRIN, INC., a late-stage clinical biopharma company focused on accelerating the...
RayzeBio Propels Forward with $418 Million to Advance Targeted Radiopharmaceuticals for Cancer
San Diego, CA, September 13, 2022 (Business Wire) -- RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative...
Dentsply Sirona Appoints Simon Campion as Chief Executive Officer
Charlotte, NC, August 25, 2022 (GLOBE NEWSWIRE) -- Dentsply Sirona Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today...
Theranica Secures $45 Million Series C Funding Round
Netanya, Israel and Montclair, NJ, August 29, 2022 (PRNewswire) -- Theranica, a prescribed digital therapeutics company developing...
Hobbs Medical Appoints New President
Stafford Springs, CT, August 24, 2022 (PRNewswire) -- The Board of Directors for Hobbs Medical, Inc., today announces the appointment...
Bain Capital to Buy Olympus Science-Optics Unit for $3.1 Billion
New York City, NY, August 29, 2022 (Bloomberg) -- Bain Capital agreed to buy Olympus Corp.’s scientific instruments business for 428...
Digital Diagnostics Closes $75 million Series B Funding Round led by KKR
Coralville, IA, August 23, 2022 (PRNewswire) -- Digital Diagnostics, a leading artificial intelligence diagnostic health care...
Orna Therapeutics Raises $221 Million Series B
Cambridge, MA, August 16, 2022 (PRNewswire) -- Orna Therapeutics, a biotechnology company pioneering a new class of fully engineered...
Gilead to Acquire Remaining Worldwide Rights of Trodelvy®
Foster City, CA, August 15, 2020 (BUSINESS WIRE) -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with Everest...
Philips Names New CEO Who Has Led Respiratory Device Recall
New York City, NY, August 16, 2020 (Bloomberg) -- Royal Philips NV said Roy Jakobs, who has been leading the company’s response to a...
Sanofi and Atomwise Ink Deal Worth over $1B
San Francisco, CA, July 17, 2020 (BUSINESS WIRE) -- Atomwise, a leader in using artificial intelligence (AI) for small molecule drug...
Poseida inks deal with Roche for $110M initially and potentially $6B in aggregate value.
San Diego, CA, August, 3, 2022 (street insider) — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company...